Jovana Ilic, Christoph Koelbl, Friederike Simon, Maximiliane Wußmann, Regina Ebert, Drenka Trivanovic, Marietta Herrmann
{"title":"用于多发性骨髓瘤体外研究的液体覆盖和胶原蛋白三维模型","authors":"Jovana Ilic, Christoph Koelbl, Friederike Simon, Maximiliane Wußmann, Regina Ebert, Drenka Trivanovic, Marietta Herrmann","doi":"10.1089/ten.TEC.2023.0374","DOIUrl":null,"url":null,"abstract":"<p><p>Multiple myeloma (MM) clones reside in the bone marrow (BM), which plays a role in its survival and development. The interactions between MM and their neighboring mesenchymal stromal cells (MSCs) have been shown to promote MM growth and drug resistance. However, those interactions are often missing or misrepresented in traditional two-dimensional (2D) culture models. Application of novel three-dimensional (3D) models might recapitulate the BM niche more precisely, which will offer new insights into MM progression and survival. Here, we aimed to establish two 3D models, based on MSC spheroids and collagen droplets incorporating both MM cells and MSCs with the goal of replicating the native myeloma context of the BM niche. This approach revealed that although MSCs can spontaneously assemble spheroids with altered metabolic traits, MSC spheroid culture does not support the integration of MM cells. On the contrary, collagen-droplet culture supported the growth of both cell types. In collagen, MSC proliferation was reduced, with the correlating decrease in ATP production and Ki-67 expression, which might resemble <i>in vivo</i> conditions, rather than 2D abundance of nutrients and space. MSCs and MMs were distributed homogenously throughout the collagen droplet, with an apparent CXCL12 expression in MSCs. In addition, the response of MM cells to bortezomib was substantially reduced in collagen, indicating the importance of 3D culture in the investigation of myeloma cell behavior, as drug resistance is one of the most pertinent issues in cancer therapy.</p>","PeriodicalId":23154,"journal":{"name":"Tissue engineering. Part C, Methods","volume":" ","pages":"193-205"},"PeriodicalIF":2.7000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Liquid Overlay and Collagen-Based Three-Dimensional Models for <i>In Vitro</i> Investigation of Multiple Myeloma.\",\"authors\":\"Jovana Ilic, Christoph Koelbl, Friederike Simon, Maximiliane Wußmann, Regina Ebert, Drenka Trivanovic, Marietta Herrmann\",\"doi\":\"10.1089/ten.TEC.2023.0374\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Multiple myeloma (MM) clones reside in the bone marrow (BM), which plays a role in its survival and development. The interactions between MM and their neighboring mesenchymal stromal cells (MSCs) have been shown to promote MM growth and drug resistance. However, those interactions are often missing or misrepresented in traditional two-dimensional (2D) culture models. Application of novel three-dimensional (3D) models might recapitulate the BM niche more precisely, which will offer new insights into MM progression and survival. Here, we aimed to establish two 3D models, based on MSC spheroids and collagen droplets incorporating both MM cells and MSCs with the goal of replicating the native myeloma context of the BM niche. This approach revealed that although MSCs can spontaneously assemble spheroids with altered metabolic traits, MSC spheroid culture does not support the integration of MM cells. On the contrary, collagen-droplet culture supported the growth of both cell types. In collagen, MSC proliferation was reduced, with the correlating decrease in ATP production and Ki-67 expression, which might resemble <i>in vivo</i> conditions, rather than 2D abundance of nutrients and space. MSCs and MMs were distributed homogenously throughout the collagen droplet, with an apparent CXCL12 expression in MSCs. In addition, the response of MM cells to bortezomib was substantially reduced in collagen, indicating the importance of 3D culture in the investigation of myeloma cell behavior, as drug resistance is one of the most pertinent issues in cancer therapy.</p>\",\"PeriodicalId\":23154,\"journal\":{\"name\":\"Tissue engineering. Part C, Methods\",\"volume\":\" \",\"pages\":\"193-205\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2024-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Tissue engineering. Part C, Methods\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1089/ten.TEC.2023.0374\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/4/17 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"CELL & TISSUE ENGINEERING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tissue engineering. Part C, Methods","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/ten.TEC.2023.0374","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/4/17 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CELL & TISSUE ENGINEERING","Score":null,"Total":0}
引用次数: 0
摘要
多发性骨髓瘤(MM)克隆存在于骨髓(BM)中,BM 在骨髓瘤的生存和发展中发挥着作用。多发性骨髓瘤及其邻近间充质基质细胞(MSCs)之间的相互作用已被证明能促进多发性骨髓瘤的生长和耐药性。然而,这些相互作用在传统的二维(2D)培养模型中往往缺失或被错误地描述。应用新型三维(3D)模型可能会更精确地再现骨髓干细胞龛,从而为了解骨髓瘤的进展和存活提供新的视角。在这里,我们旨在建立两种三维模型,它们分别基于间充质干细胞球和胶原液滴,同时包含 MM 细胞和间充质干细胞,目的是复制骨髓瘤的原生生物龛。这种方法发现,虽然间充质干细胞能自发形成具有改变代谢特征的球体,但自组装的间充质干细胞球体培养并不支持 MM 细胞的整合。另一方面,胶原液滴培养支持两种细胞类型的生长。在胶原蛋白中,间充质干细胞增殖减少,ATP生成和Ki-67表达也相应减少,这可能与体内条件相似,而不是二维营养物质和空间的丰富。间充质干细胞和干细胞均匀地分布在整个胶原液滴中,间充质干细胞有明显的 CXCL12 表达。此外,MM 细胞对硼替佐米的反应在胶原蛋白中大大降低,这表明三维培养在研究骨髓瘤细胞行为中的重要性,因为耐药性是癌症治疗中最相关的问题之一。影响声明:三维模型在多发性骨髓瘤研究中的应用将使我们更好地了解骨髓瘤的行为和耐药性,从而制定出更好的治疗策略。在这里,我们优化了一种基于胶原蛋白的方法,该方法具有可重复性和成本效益,并已在治疗反应中提供了改变反馈。
Liquid Overlay and Collagen-Based Three-Dimensional Models for In Vitro Investigation of Multiple Myeloma.
Multiple myeloma (MM) clones reside in the bone marrow (BM), which plays a role in its survival and development. The interactions between MM and their neighboring mesenchymal stromal cells (MSCs) have been shown to promote MM growth and drug resistance. However, those interactions are often missing or misrepresented in traditional two-dimensional (2D) culture models. Application of novel three-dimensional (3D) models might recapitulate the BM niche more precisely, which will offer new insights into MM progression and survival. Here, we aimed to establish two 3D models, based on MSC spheroids and collagen droplets incorporating both MM cells and MSCs with the goal of replicating the native myeloma context of the BM niche. This approach revealed that although MSCs can spontaneously assemble spheroids with altered metabolic traits, MSC spheroid culture does not support the integration of MM cells. On the contrary, collagen-droplet culture supported the growth of both cell types. In collagen, MSC proliferation was reduced, with the correlating decrease in ATP production and Ki-67 expression, which might resemble in vivo conditions, rather than 2D abundance of nutrients and space. MSCs and MMs were distributed homogenously throughout the collagen droplet, with an apparent CXCL12 expression in MSCs. In addition, the response of MM cells to bortezomib was substantially reduced in collagen, indicating the importance of 3D culture in the investigation of myeloma cell behavior, as drug resistance is one of the most pertinent issues in cancer therapy.
期刊介绍:
Tissue Engineering is the preeminent, biomedical journal advancing the field with cutting-edge research and applications that repair or regenerate portions or whole tissues. This multidisciplinary journal brings together the principles of engineering and life sciences in the creation of artificial tissues and regenerative medicine. Tissue Engineering is divided into three parts, providing a central forum for groundbreaking scientific research and developments of clinical applications from leading experts in the field that will enable the functional replacement of tissues.
Tissue Engineering Methods (Part C) presents innovative tools and assays in scaffold development, stem cells and biologically active molecules to advance the field and to support clinical translation. Part C publishes monthly.